Reproducibility of quantitative dynamic MRI of normal human tissues

NMR in Biomedicine

Volumn 15, Issue 2, 2002, Pages 143-153

  Padhani, Anwar R ^a,c   Hayes, Carmel ^a   Landau, Sabine ^b   Leach, Martin O ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Contrast media; Dynamic MRI; Normal tissues; Permeability

Indexed keywords

MEDICAL APPLICATIONS; MUSCLE; TUMORS;

CLINICAL RESEARCH;

BIOMEDICAL ENGINEERING;

ANDROGEN; ANTIANDROGEN; CONTRAST MEDIUM; CYPROTERONE ACETATE; GADOLINIUM PENTETATE; GONADORELIN ANTAGONIST;

ADIPOSE TISSUE; AGED; ARTICLE; BIOACCUMULATION; BONE MARROW; CANCER HORMONE THERAPY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; CONTRAST MEDIUM EXTRAVASATION; CONTROLLED STUDY; FEMUR HEAD; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; ISCHIUM; MALE; NORMAL VALUE; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS RADIOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; QUANTITATIVE ANALYSIS; QUANTITATIVE DIAGNOSIS; REPRODUCIBILITY; STATISTICAL ANALYSIS; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

ADIPOSE TISSUE; BONE MARROW; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE, SKELETAL; PELVIS; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 0036199430     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/nbm.732     Document Type: Article

References (33)

1. In vivo monitoring of tumor angiogenesis with MR imaging
2. Modelling tracer kinetics in dynamic Gd-DTPA MR imaging
3. Pharmacokinetic analysis of neoplasms using contrast-enhanced dynamic magnetic resonance imaging
4. Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with MR imaging
5. Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging
6. Dynamic MR imaging (DEMRI) of microcirculation in bone sarcoma
7. Monitoring of tumor microcirculation during fractionated radiation therapy in patients with rectal carcinoma: Preliminary results and implications for therapy
8. Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer
9. Uterine fibroleiomyoma: MR imaging appearances before and after embolization of uterine arteries
10. Symptomatic fibroleiomyomata: MR imaging of the uterus before and after uterine arterial embolization
11. Semi-quantitative assessment of uterine perfusion using first pass dynamic contrast-enhanced MR imaging for patients treated with uterine fibroid embolization
12. Key factors in the acquisition of contrast kinetic data for oncology
13. Therapeutic angiogenesis
14. Stimulation of peripheral angiogenesis by vascular endothelial growth factor (VEGF)
15. Probing tumor microvessel density by measurement, analysis and display of contrast agent uptake kinetics
16. 1 measurements using saturation recovery Turbo-FLASH with approximate K-space normalisation filter
17. MRIW: Parametric analysis software for contrast-enhanced dynamic MR imaging in cancer
18. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model
19. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: Standardized quantities and symbols
20. Studies of Gd-DTPA relaxivity and proton exchange rates in tissue
21. Statistics notes: Measurement error
22. Statistics notes: Measurement error proportional to the mean
23. Forming inferences about some intraclass correlation coefficients
24. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy
25. Response of breast carcinoma to chemotherapy-MR permeability changes using histogram analysis
26. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: Value of dynamic MR imaging in detecting viable tumor before surgery
27. MRI of avascular necrosis of bone
28. Dynamic MR enhancement in prostate cancer: Correlation with morphology and MRI stage, histological grade and serum PSA
29. Dynamic T1-weighted magnetic resonance imaging and positron emission tomography in patients with lung cancer: Correlating vascular physiology with glucose metabolism
30. MR imaging of the breast with Gd-DTPA: Use and limitations
31. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
32. Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: Role of vascular endothelial growth factor
33. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: Implications for antiangiogenic tumor therapies